{"id":85684,"date":"2026-11-16T11:35:00","date_gmt":"2026-11-16T10:35:00","guid":{"rendered":"https:\/\/www.teoresigroup.com\/?p=85684"},"modified":"2026-11-16T11:39:29","modified_gmt":"2026-11-16T10:39:29","slug":"progress-bnct-cnao-teoresigroup","status":"publish","type":"post","link":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/","title":{"rendered":"Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche"},"content":{"rendered":"\n<div class=\"wp-block-columns row align-center row sezione\">\n<div class=\"wp-block-column column small-12 medium-10 large-8\">\n<p>Teoresi Group (gi\u00e0 HiFuture S.r.l.) partecipa a <strong>PROGRESS BNCT@CNAO <\/strong>(ID 6170035), il <strong>progetto di ricerca dedicato allo sviluppo della nuova struttura per la BNCT <\/strong>presso il Centro Nazionale di Adroterapia Oncologica. L\u2019iniziativa riceve il <strong>sostegno finanziario dell\u2019Unione europea, della Repubblica Italiana e di Regione Lombardia, nell\u2019ambito del PR FESR 2021-2027 di Regione Lombardia, bando Collabora &amp; Innova.<\/strong><\/p>\n\n\n\n<p>Il progetto riunisce competenze della ricerca, delle istituzioni cliniche e dell\u2019industria per promuovere l\u2019innovazione nelle terapie oncologiche ad alta tecnologia sul territorio lombardo.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-verso-nuove-possibilita-di-trattamento\">Verso nuove possibilit\u00e0 di trattamento<\/h2>\n\n\n\n<p><strong>PROGRESS BNCT@CNAO ha l\u2019obiettivo di realizzare un ecosistema preclinico integrato dedicato alla BNCT<\/strong>, la terapia per cattura neutronica del boro, e di favorire lo sviluppo di opzioni di trattamento ad alta complessit\u00e0 tecnologica per pazienti con tumori di difficile trattamento, come le recidive del distretto testa-collo.<\/p>\n\n\n\n<p>Nei <strong>27 mesi di durata del progetto<\/strong>, il partenariato lavorer\u00e0 alla preparazione del<strong> Dossier dello Sperimentatore<\/strong>, il risultato atteso al termine delle attivit\u00e0. Questo documento costituisce un passaggio fondamentale e propedeutico all\u2019avvio dell\u2019indagine clinica, che sar\u00e0 subordinato al parere degli enti autorizzativi.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-il-contributo-di-teoresi-group\">Il contributo di Teoresi Group<\/h2>\n\n\n\n<p><strong>Teoresi contribuisce al progetto<\/strong> con le proprie competenze nell\u2019<strong>intelligenza artificiale<\/strong>, nell\u2019<strong>analisi dei rischi<\/strong> e nell\u2019<strong>integrazione software<\/strong>, concentrandosi su tre ambiti di attivit\u00e0.<\/p>\n\n\n\n<p>Il primo riguarda l\u2019<strong>automazione della segmentazione degli organi umani con il supporto dell\u2019intelligenza artificiale<\/strong>, per identificarli e delimitarli nelle immagini mediche ai fini del trattamento BNCT.<\/p>\n\n\n\n<p>Il secondo prevede il supporto all\u2019<strong>applicazione della metodologia FMEA all\u2019intero ciclo di erogazione della terapia<\/strong>, condotta insieme a CNAO in conformit\u00e0 alle norme ISO 14971 e ISO 14155. Questa metodologia permette di analizzare le possibili modalit\u00e0 di guasto e i loro effetti, contribuendo alla gestione dei rischi connessi al trattamento.<\/p>\n\n\n\n<p>Il terzo riguarda l\u2019<strong>integrazione software della BNCT nei sistemi clinici e gestionali di CNAO<\/strong>, per supportare l\u2019inserimento della terapia nei flussi operativi del centro.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-una-collaborazione-tra-ricerca-clinica-e-industria\">Una collaborazione tra ricerca, clinica e industria<\/h2>\n\n\n\n<p>Il progetto vede come capofila <strong><a href=\"https:\/\/fondazionecnao.it\/news\/finanziamento-progetto-PROGRESS\" target=\"_blank\" rel=\"noreferrer noopener\">Fondazione CNAO \u2013 Centro Nazionale di Adroterapia Oncologica<\/a>,<\/strong> affiancata da Teoresi Group, <strong><a href=\"https:\/\/www.sanmatteo.org\/abstract-progress-bnctcnao\" target=\"_blank\" rel=\"noreferrer noopener\">Fondazione IRCCS Policlinico San Matteo<\/a>, <a href=\"https:\/\/www.raylab.solutions\/2025\/08\/20\/cei_progress_2025\/\" target=\"_blank\" rel=\"noreferrer noopener\">Raylab S.r.l.<\/a>, <a href=\"https:\/\/www.visiorobotics.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Visiorobotics S.r.l.<\/a> <\/strong>e <a href=\"https:\/\/www.elsesolutions.com\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>ELSE Solutions S.r.l.<\/strong><\/a><\/p>\n\n\n\n<p>La collaborazione tra i partner unisce competenze complementari per sostenere lo sviluppo della nuova facility BNCT e preparare il percorso verso la sperimentazione clinica.<\/p>\n\n\n\n<p><strong>Per maggiori informazioni sul Programma Regionale FESR 2021-2027 e sul bando Collabora &amp; Innova, visita il <a href=\"https:\/\/fesr.regione.lombardia.it\/\" target=\"_blank\" rel=\"noreferrer noopener\">sito di Regione Lombardia.<\/a><\/strong><\/p>\n\n\n<figure class=\"wp-block-figure \" style=\"\" data-url=\"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2026\/11\/banner-bianco-rettangolare.png\" data-size=\"856x115\" ><img decoding=\"async\" class=\"b-lazy wp-block-image \" style=\"\" src=\"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2024\/09\/teoresi-favicon2024.png\" itemprop=\"thumbnail\" data-src=\"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2026\/11\/banner-bianco-rettangolare-640x86.png|https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2026\/11\/banner-bianco-rettangolare.png|https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2026\/11\/banner-bianco-rettangolare.png\" alt=\"banner_bianco_rettangolare\" width=\"640\" height=\"86\" \/><figcaption class=\"image-caption block\"><\/figcaption><\/figure><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p class=\"excerpt\">Teoresi Group (gi\u00e0 HiFuture S.r.l.) partecipa a PROGRESS BNCT@CNAO (ID 6170035), il progetto di ricerca dedicato allo sviluppo della nuova struttura per la BNCT presso il Centro Nazionale di Adroterapia Oncologica. L\u2019iniziativa riceve il sostegno finanziario dell\u2019Unione europea, della Repubblica Italiana e di Regione Lombardia, nell\u2019ambito del PR FESR 2021-2027 di Regione Lombardia, bando Collabora &amp; Innova. Il progetto riunisce&#8230;<\/p>\n","protected":false},"author":14,"featured_media":85710,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-85684","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corporate"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.7 (Yoast SEO v28.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche - Teoresi Group<\/title>\n<meta name=\"description\" content=\"Teoresi Group partecipa a PROGRESS BNCT@CNAO con competenze in intelligenza artificiale e analisi dei rischi. Scopri gli obiettivi del progetto.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche\" \/>\n<meta property=\"og:description\" content=\"Teoresi Group partecipa a PROGRESS BNCT@CNAO con competenze in intelligenza artificiale e analisi dei rischi. Scopri gli obiettivi del progetto.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/\" \/>\n<meta property=\"og:site_name\" content=\"Teoresi Group\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/Gruppo-Teoresi\/118393464917205\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-16T10:35:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-16T10:39:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2026\/11\/bnct-teoresigroup-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1009\" \/>\n\t<meta property=\"og:image:height\" content=\"757\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Giulia Potenza\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Giulia Potenza\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/\"},\"author\":{\"name\":\"Giulia Potenza\",\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/#\\\/schema\\\/person\\\/7a1a1e96684a9db98fbacac16e4170b3\"},\"headline\":\"Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche\",\"datePublished\":\"2026-11-16T10:35:00+00:00\",\"dateModified\":\"2026-11-16T10:39:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/\"},\"wordCount\":420,\"publisher\":{\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.teoresigroup.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/bnct-teoresigroup-1.png\",\"articleSection\":[\"Corporate\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/\",\"url\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/\",\"name\":\"Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche - Teoresi Group\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.teoresigroup.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/bnct-teoresigroup-1.png\",\"datePublished\":\"2026-11-16T10:35:00+00:00\",\"dateModified\":\"2026-11-16T10:39:29+00:00\",\"description\":\"Teoresi Group partecipa a PROGRESS BNCT@CNAO con competenze in intelligenza artificiale e analisi dei rischi. Scopri gli obiettivi del progetto.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.teoresigroup.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/bnct-teoresigroup-1.png\",\"contentUrl\":\"https:\\\/\\\/www.teoresigroup.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/bnct-teoresigroup-1.png\",\"width\":1009,\"height\":757,\"caption\":\"PROGRESS BNCT@CNAO: Teoresi Group partecipa al progetto di ricerca e sviluppo sperimentale dedicato alla terapia per cattura neutronica del boro.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/news\\\/progress-bnct-cnao-teoresigroup\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/\",\"name\":\"Teoresi Group\",\"description\":\"Engineering for Human life.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/#organization\",\"name\":\"Teoresi Group\",\"url\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.teoresigroup.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/teoresi-logo-color.svg\",\"contentUrl\":\"https:\\\/\\\/www.teoresigroup.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/teoresi-logo-color.svg\",\"width\":1,\"height\":1,\"caption\":\"Teoresi Group\"},\"image\":{\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pages\\\/Gruppo-Teoresi\\\/118393464917205\",\"https:\\\/\\\/www.instagram.com\\\/teoresigroup\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/teoresigroup\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCNdBBSSax2EWPmFk5QzYP8Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.teoresigroup.com\\\/it\\\/#\\\/schema\\\/person\\\/7a1a1e96684a9db98fbacac16e4170b3\",\"name\":\"Giulia Potenza\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/460d46e50e232e6411af2becf8aaf087c063d1eb5ea75118867964f7f14d7b08?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/460d46e50e232e6411af2becf8aaf087c063d1eb5ea75118867964f7f14d7b08?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/460d46e50e232e6411af2becf8aaf087c063d1eb5ea75118867964f7f14d7b08?s=96&d=mm&r=g\",\"caption\":\"Giulia Potenza\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche - Teoresi Group","description":"Teoresi Group partecipa a PROGRESS BNCT@CNAO con competenze in intelligenza artificiale e analisi dei rischi. Scopri gli obiettivi del progetto.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/","og_locale":"it_IT","og_type":"article","og_title":"Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche","og_description":"Teoresi Group partecipa a PROGRESS BNCT@CNAO con competenze in intelligenza artificiale e analisi dei rischi. Scopri gli obiettivi del progetto.","og_url":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/","og_site_name":"Teoresi Group","article_publisher":"https:\/\/www.facebook.com\/pages\/Gruppo-Teoresi\/118393464917205","article_published_time":"2026-11-16T10:35:00+00:00","article_modified_time":"2026-11-16T10:39:29+00:00","og_image":[{"width":1009,"height":757,"url":"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2026\/11\/bnct-teoresigroup-1.png","type":"image\/png"}],"author":"Giulia Potenza","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Giulia Potenza","Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/#article","isPartOf":{"@id":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/"},"author":{"name":"Giulia Potenza","@id":"https:\/\/www.teoresigroup.com\/it\/#\/schema\/person\/7a1a1e96684a9db98fbacac16e4170b3"},"headline":"Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche","datePublished":"2026-11-16T10:35:00+00:00","dateModified":"2026-11-16T10:39:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/"},"wordCount":420,"publisher":{"@id":"https:\/\/www.teoresigroup.com\/it\/#organization"},"image":{"@id":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/#primaryimage"},"thumbnailUrl":"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2026\/11\/bnct-teoresigroup-1.png","articleSection":["Corporate"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/","url":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/","name":"Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche - Teoresi Group","isPartOf":{"@id":"https:\/\/www.teoresigroup.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/#primaryimage"},"image":{"@id":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/#primaryimage"},"thumbnailUrl":"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2026\/11\/bnct-teoresigroup-1.png","datePublished":"2026-11-16T10:35:00+00:00","dateModified":"2026-11-16T10:39:29+00:00","description":"Teoresi Group partecipa a PROGRESS BNCT@CNAO con competenze in intelligenza artificiale e analisi dei rischi. Scopri gli obiettivi del progetto.","breadcrumb":{"@id":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/#primaryimage","url":"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2026\/11\/bnct-teoresigroup-1.png","contentUrl":"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2026\/11\/bnct-teoresigroup-1.png","width":1009,"height":757,"caption":"PROGRESS BNCT@CNAO: Teoresi Group partecipa al progetto di ricerca e sviluppo sperimentale dedicato alla terapia per cattura neutronica del boro."},{"@type":"BreadcrumbList","@id":"https:\/\/www.teoresigroup.com\/it\/news\/progress-bnct-cnao-teoresigroup\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/www.teoresigroup.com\/it\/"},{"@type":"ListItem","position":2,"name":"Dalla ricerca alla cura: Teoresi Group nel progetto PROGRESS BNCT@CNAO per l\u2019innovazione nelle terapie oncologiche"}]},{"@type":"WebSite","@id":"https:\/\/www.teoresigroup.com\/it\/#website","url":"https:\/\/www.teoresigroup.com\/it\/","name":"Teoresi Group","description":"Engineering for Human life.","publisher":{"@id":"https:\/\/www.teoresigroup.com\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.teoresigroup.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.teoresigroup.com\/it\/#organization","name":"Teoresi Group","url":"https:\/\/www.teoresigroup.com\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.teoresigroup.com\/it\/#\/schema\/logo\/image\/","url":"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2020\/12\/teoresi-logo-color.svg","contentUrl":"https:\/\/www.teoresigroup.com\/wp-content\/uploads\/2020\/12\/teoresi-logo-color.svg","width":1,"height":1,"caption":"Teoresi Group"},"image":{"@id":"https:\/\/www.teoresigroup.com\/it\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pages\/Gruppo-Teoresi\/118393464917205","https:\/\/www.instagram.com\/teoresigroup\/","https:\/\/www.linkedin.com\/company\/teoresigroup\/","https:\/\/www.youtube.com\/channel\/UCNdBBSSax2EWPmFk5QzYP8Q"]},{"@type":"Person","@id":"https:\/\/www.teoresigroup.com\/it\/#\/schema\/person\/7a1a1e96684a9db98fbacac16e4170b3","name":"Giulia Potenza","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/460d46e50e232e6411af2becf8aaf087c063d1eb5ea75118867964f7f14d7b08?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/460d46e50e232e6411af2becf8aaf087c063d1eb5ea75118867964f7f14d7b08?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/460d46e50e232e6411af2becf8aaf087c063d1eb5ea75118867964f7f14d7b08?s=96&d=mm&r=g","caption":"Giulia Potenza"}}]}},"_links":{"self":[{"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/posts\/85684","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/comments?post=85684"}],"version-history":[{"count":6,"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/posts\/85684\/revisions"}],"predecessor-version":[{"id":85721,"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/posts\/85684\/revisions\/85721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/media\/85710"}],"wp:attachment":[{"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/media?parent=85684"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/categories?post=85684"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.teoresigroup.com\/it\/wp-json\/wp\/v2\/tags?post=85684"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}